Fayez Sarofim & Co Portfolio holdings
AUM
$41.7B
This Quarter Return
+6.77%
1 Year Return
+15.12%
3 Year Return
+67.65%
5 Year Return
+130.07%
10 Year Return
+262.45%
AUM
$28.6B
AUM Growth
+$28.6B
(-0.06%)
Cap. Flow
-$1.67B
Cap. Flow
% of AUM
-5.84%
Top 10 Holdings %
Top 10 Hldgs %
43.66%
Holding
291
New
10
Increased
60
Reduced
139
Closed
13
Top Buys
| 1 |
CME Group
CME
|
$45.7M |
| 2 |
AstraZeneca
AZN
|
$36.8M |
| 3 |
EOG Resources
EOG
|
$23.5M |
| 4 |
UnitedHealth
UNH
|
$19.7M |
| 5 |
Eli Lilly
LLY
|
$15.9M |
Top Sells
| 1 |
Microsoft
MSFT
|
$165M |
| 2 |
Apple
AAPL
|
$137M |
| 3 |
Bank of New York Mellon
BK
|
$133M |
| 4 |
Procter & Gamble
PG
|
$130M |
| 5 |
Chevron
CVX
|
$109M |
Sector Composition
| 1 | Technology | 25.27% |
| 2 | Financials | 17.16% |
| 3 | Consumer Staples | 16.61% |
| 4 | Energy | 11.67% |
| 5 | Healthcare | 11.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$3.45T
| $2.96B | 10.36% | 15,248,555 -707,192 | -4% | -$137M |
|
|
2
Microsoft
MSFT
$3.77T
| $2.32B | 8.12% | 6,809,669 -485,721 | -7% | -$165M |
|
3
Philip Morris
PM
$260B
| $1.2B | 4.2% | 12,290,227 -870,518 | -7% | -$85M |
|
4
Coca-Cola
KO
$297B
| $1.12B | 3.92% | 18,608,486 -878,048 | -5% | -$52.9M |
|
5
Exxon Mobil
XOM
$487B
| $1.06B | 3.72% | 9,891,942 -657,588 | -6% | -$70.5M |
|
6
T Rowe Price
TROW
$23.6B
| $839M | 2.94% | 7,491,415 -72,125 | -1% | -$8.08M |
|
7
Novo Nordisk
NVO
$251B
| $829M | 2.9% | 5,119,685 -160,672 | -3% | -$26M |
|
|
8
Chevron
CVX
$324B
| $804M | 2.81% | 5,108,005 -695,712 | -12% | -$109M |
|
9
Amazon
AMZN
$2.44T
| $680M | 2.38% | 5,214,348 +18,632 | +0.4% | +$2.43M |
|
10
Alphabet (Google) Class C
GOOG
$2.58T
| $658M | 2.3% | 5,439,144 -155,509 | -3% | -$18.8M |
|
11
McDonald's
MCD
$224B
| $630M | 2.21% | 2,110,847 -55,570 | -3% | -$16.6M |
|
12
Visa
V
$683B
| $628M | 2.2% | 2,642,563 -23,284 | -0.9% | -$5.53M |
|
13
JPMorgan Chase
JPM
$829B
| $619M | 2.17% | 4,255,147 -429,701 | -9% | -$62.5M |
|
14
Texas Instruments
TXN
$184B
| $600M | 2.1% | 3,331,024 -35,955 | -1% | -$6.47M |
|
|
HES
15
DELISTED
Hess
HES
| $571M | 2% | 4,202,815 -156,708 | -4% | -$21.3M |
|
16
PepsiCo
PEP
$204B
| $545M | 1.91% | 2,944,060 -28,394 | -1% | -$5.26M |
|
17
S&P Global
SPGI
$167B
| $544M | 1.9% | 1,356,766 -13,895 | -1% | -$5.57M |
|
|
18
UnitedHealth
UNH
$281B
| $536M | 1.88% | 1,115,478 +41,087 | +4% | +$19.7M |
|
|
19
Procter & Gamble
PG
$368B
| $524M | 1.84% | 3,453,313 -855,960 | -20% | -$130M |
|
20
Union Pacific
UNP
$133B
| $483M | 1.69% | 2,359,951 -63,055 | -3% | -$12.9M |
|
21
Altria Group
MO
$113B
| $439M | 1.54% | 9,697,591 -1,822,315 | -16% | -$82.6M |
|
22
Enterprise Products Partners
EPD
$69.6B
| $438M | 1.53% | 16,631,863 +62,558 | +0.4% | +$1.65M |
|
23
Air Products & Chemicals
APD
$65.5B
| $435M | 1.52% | 1,451,334 -13,181 | -0.9% | -$3.95M |
|
24
Abbott
ABT
$231B
| $429M | 1.5% | 3,931,137 -148,160 | -4% | -$16.2M |
|
25
Blackrock
BLK
$175B
| $400M | 1.4% | 579,424 +10,738 | +2% | +$7.42M |
|